Source: Eur Respir J 2009; 33: 489-506



Rating:

Share or cite this content

Citations should be made in the following way:
Ocak S., Sos M. L., Thomas R. K., Massion P. P.. High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications. Eur Respir J 2009; 33: 489-506

Member's Comments

No comment yet.

Related content which might interest you: Pathology and molecular biology of lung cancer Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer Year: 2006 New findings in the molecular biology of lung cancer: clinical application Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Pathogenesis of lung cancer signalling pathways: roadmap for therapies Source: Eur Respir J 2009; 33: 1485-1497 Year: 2009 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Radiomics in lung cancer: progress and challenges Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Modern molecular lung cancer diagnostics – how to use and interpret it wisely Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 The biology of lung cancer Source: Eur Respir Mon; 2009: 44: 88–105 Year: 2009 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Stem cells, lung pathogenesis and therapeutic potential Source: Annual Congress 2005 - Scientific year in review Year: 2005 Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Source: Eur Respir J 2002; 20: 464-479 Year: 2002 Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016